{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T15:26:04Z","timestamp":1784042764216,"version":"3.55.0"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,28]],"date-time":"2020-12-28T00:00:00Z","timestamp":1609113600000},"content-version":"vor","delay-in-days":88,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001721","name":"Rijksuniversiteit Groningen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001721","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014072","name":"Amsterdams Universiteitsfonds","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014072","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002999","name":"Ministerie van Volksgezondheid, Welzijn en Sport","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002999","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003195","name":"Ministerie van Economische Zaken","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003195","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005075","name":"Universitair Medisch Centrum Groningen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005075","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.jad.2020.06.040","type":"journal-article","created":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T21:51:55Z","timestamp":1594677115000},"page":"230-237","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Association between skin autofluorescence of advanced glycation end products and affective disorders in the lifelines cohort study"],"prefix":"10.1016","volume":"275","author":[{"given":"Julia M.","family":"Hagen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjen L.","family":"Sutterland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo A.L.","family":"da Fonseca Pereira de Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederike","family":"Schirmbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny M.","family":"Cohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Lok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanno L.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aeilko H.","family":"Zwinderman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lieuwe","family":"de Haan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2020.06.040_bib0001","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/01.crd.0000380842.14048.7e","article-title":"Diagnosis and management of the metabolic syndrome. An American heart association\/national heart, lung, and blood institute scientific statement. Executive summary","volume":"13","author":"Grundy","year":"2005","journal-title":"Cardiol. Rev."},{"key":"10.1016\/j.jad.2020.06.040_bib0002","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.psychres.2002.12.004","article-title":"Antioxidant enzyme and malondialdehyde levels in patients with social phobia","volume":"159","author":"Atmaca","year":"2008","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2020.06.040_bib0003","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1192\/bjp.bp.114.156554","article-title":"Anxiety and new onset of cardiovascular disease: critical review and meta-analysis","volume":"208","author":"Batelaan","year":"2016","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2020.06.040_bib0004","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.psyneuen.2014.09.025","article-title":"Is depression associated with increased oxidative stress? A systematic review and meta-analysis","volume":"51","author":"Black","year":"2015","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jad.2020.06.040_bib0005","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1017\/S0033291716002828","article-title":"Oxidative stress in major depressive and anxiety disorders, and the association with antidepressant use; results from a large adult cohort","volume":"47","author":"Black","year":"2017","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2020.06.040_bib0006","doi-asserted-by":"crossref","first-page":"e743","DOI":"10.1038\/tp.2016.5","article-title":"Oxidative stress, anti-oxidants and the cross-sectional and longitudinal association with depressive symptoms: results from the CARDIA study","volume":"6","author":"Black","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jad.2020.06.040_bib0007","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4161\/oxim.2.2.7944","article-title":"Oxidative stress and anxiety: relationship and cellular pathways","volume":"2","author":"Bouayed","year":"2009","journal-title":"Oxid. Med. Cell Longev."},{"key":"10.1016\/j.jad.2020.06.040_bib0008","doi-asserted-by":"crossref","first-page":"369","DOI":"10.4310\/SII.2009.v2.n3.a10","article-title":"Penalized methods for bi-level variable selection","volume":"2","author":"Breheny","year":"2009","journal-title":"Stat Interface"},{"key":"10.1016\/j.jad.2020.06.040_bib0009","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.euroneuro.2019.05.010","article-title":"Increased serum levels of leptin and insulin in both schizophrenia and major depressive disorder: a cross-disorder proteomics analysis","volume":"29","author":"Cakici","year":"2019","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2020.06.040_bib0010","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1017\/S0033291712000554","article-title":"Generalized anxiety and C-reactive protein levels: a prospective, longitudinal analysis","volume":"42","author":"Copeland","year":"2012","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2020.06.040_bib0011","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00127-010-0334-8","article-title":"Prevalence of mental disorders and trends from 1996 to 2009. Results from the Netherlands Mental Health Survey and Incidence Study-2","volume":"47","author":"de Graaf","year":"2012","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"key":"10.1016\/j.jad.2020.06.040_bib0012","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1176\/appi.ajp.2007.06091492","article-title":"Nonresponse to treatment for depression following myocardial infarction: association with subsequent cardiac events","volume":"164","author":"de Jonge","year":"2007","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2020.06.040_bib0013","article-title":"Shorter telomere length in carriers of APOE-epsilon4 and high plasma concentration of glucose, glyoxal and other advanced glycation end products (AGEs)","author":"Dhillon","year":"2019","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.jad.2020.06.040_bib0014","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1001\/jama.1993.03510150053029","article-title":"Depression following myocardial infarction. Impact on 6-month survival","volume":"270","author":"Frasure-Smith","year":"1993","journal-title":"JAMAJAMA"},{"key":"10.1016\/j.jad.2020.06.040_bib0015","article-title":"Day to day variability and reliability of blood oxidative stress markers within a four-week period in healthy young men","volume":"2014","author":"Goldfarb","year":"2014","journal-title":"J. Biomark."},{"key":"10.1016\/j.jad.2020.06.040_bib0016","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1161\/CIRCULATIONAHA.106.621854","article-title":"Advanced glycation end products: sparking the development of diabetic vascular injury","volume":"114","author":"Goldin","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jad.2020.06.040_bib0017","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.4088\/JCP.16m10972","article-title":"Advanced glycation end products in recent-onset psychosis indicate early onset of cardiovascular risk","volume":"78","author":"Hagen","year":"2017","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2020.06.040_bib0018","unstructured":"Hagen, J.M., Sutterland, A.L., Liefers, T., Schirmbeck, N.F., Cohn, D.M., Lok, A., Tan, H.L., Zwinderman, A.H., de Haan, L., Manuscript under review. Advanced glycation end products and mortality in affective disorders in the Lifelines cohort study: a mediation analysis."},{"key":"10.1016\/j.jad.2020.06.040_bib0019","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1196\/annals.1333.037","article-title":"Accumulation of advanced glycation end products, measured as skin autofluorescence, in renal disease","volume":"1043","author":"Hartog","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jad.2020.06.040_bib0020","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.ejheart.2007.09.009","article-title":"Advanced glycation end-products (AGEs) and heart failure: pathophysiology and clinical implications","volume":"9","author":"Hartog","year":"2007","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.jad.2020.06.040_bib0021","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.psychres.2016.12.014","article-title":"Changes in cytokine and chemokine expression distinguish dysthymic disorder from major depression and healthy controls","volume":"248","author":"Ho","year":"2017","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2020.06.040_bib0022","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1001\/jama.281.18.1718","article-title":"Malondialdehyde-modified LDL as a marker of acute coronary syndromes","volume":"281","author":"Holvoet","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.jad.2020.06.040_bib0023","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/PSY.0b013e3181907c1b","article-title":"Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis","volume":"71","author":"Howren","year":"2009","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.jad.2020.06.040_bib0024","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.bbi.2018.10.007","article-title":"Longitudinal association of inflammation with depressive symptoms: a 7-year cross-lagged twin difference study","volume":"75","author":"Huang","year":"2019","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jad.2020.06.040_bib0025","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.3233\/JAD-160917","article-title":"Skin autofluorescence examination as a diagnostic tool for mild cognitive impairment in healthy people","volume":"55","author":"Igase","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.jad.2020.06.040_bib0026","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jpsychires.2005.01.009","article-title":"Depression and possible cancer risk due to oxidative DNA damage","volume":"39","author":"Irie","year":"2005","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2020.06.040_bib0027","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.4088\/JCP.14r09179","article-title":"Oxidative stress and antioxidant parameters in patients with major depressive disorder compared to healthy controls before and after antidepressant treatment: results from a meta-analysis","volume":"76","author":"Jimenez-Fernandez","year":"2015","journal-title":"J. Clin. Psychiatr."},{"key":"10.1016\/j.jad.2020.06.040_bib0028","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/alcalc\/agh058","article-title":"Advanced glycation end-products in patients with chronic alcohol misuse","volume":"39","author":"Kalousova","year":"2004","journal-title":"Alcohol Alcohol."},{"key":"10.1016\/j.jad.2020.06.040_bib0029","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.2337\/diacare.24.9.1620","article-title":"Advanced glycation end products in nondiabetic patients with coronary artery disease","volume":"24","author":"Kanauchi","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jad.2020.06.040_bib0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0137203","article-title":"Representativeness of the LifeLines Cohort Study","volume":"10","author":"Klijs","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jad.2020.06.040_bib0031","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1089\/dia.2009.0113","article-title":"Reference values of skin autofluorescence","volume":"12","author":"Koetsier","year":"2010","journal-title":"Diabetes Technol. Ther."},{"key":"10.1016\/j.jad.2020.06.040_bib0032","doi-asserted-by":"crossref","first-page":"14416","DOI":"10.1364\/OE.18.014416","article-title":"Skin color independent assessment of aging using skin autofluorescence","volume":"18","author":"Koetsier","year":"2010","journal-title":"Opt. Express"},{"key":"10.1016\/j.jad.2020.06.040_bib0033","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jpsychires.2015.04.023","article-title":"Advanced glycation end products and schizophrenia: a systematic review","volume":"66-67","author":"Kouidrat","year":"2015","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2020.06.040_bib0034","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.jpsychires.2013.03.016","article-title":"Increased advanced glycation end-products (AGEs) assessed by skin autofluorescence in schizophrenia","volume":"47","author":"Kouidrat","year":"2013","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2020.06.040_bib0035","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1159\/000067810","article-title":"Antioxidant enzyme and malondialdehyde levels in patients with panic disorder","volume":"46","author":"Kuloglu","year":"2002","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.jad.2020.06.040_bib0036","article-title":"A Meta-Analysis of Oxidative Stress Markers in Depression","volume":"10","author":"Liu","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jad.2020.06.040_bib0037","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.eurpsy.2011.02.001","article-title":"The association between anxiety and C-reactive protein (CRP) levels: results from the Northern Finland 1966 birth cohort study","volume":"26","author":"Liukkonen","year":"2011","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.jad.2020.06.040_bib0038","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.bbi.2009.08.005","article-title":"Are there bi-directional associations between depressive symptoms and C-reactive protein in mid-life women?","volume":"24","author":"Matthews","year":"2010","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jad.2020.06.040_bib0039","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1007\/s00125-004-1451-2","article-title":"Simple non-invasive assessment of advanced glycation endproduct accumulation","volume":"47","author":"Meerwaldt","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.jad.2020.06.040_bib0040","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1681\/ASN.2005020144","article-title":"Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients","volume":"16","author":"Meerwaldt","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jad.2020.06.040_bib0041","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2337\/db14-0506","article-title":"Type 2 diabetes, skin autofluorescence, and brain atrophy","volume":"64","author":"Moran","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.jad.2020.06.040_bib0042","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/BF03086239","article-title":"Skin autofluorescence is elevated in acute myocardial infarction and is associated with the one-year incidence of major adverse cardiac events","volume":"17","author":"Mulder","year":"2009","journal-title":"Neth. Heart J."},{"key":"10.1016\/j.jad.2020.06.040_bib0043","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1089\/dia.2006.8.523","article-title":"Skin autofluorescence, a novel marker for glycemic and oxidative stress-derived advanced glycation endproducts: an overview of current clinical studies, evidence, and limitations","volume":"8","author":"Mulder","year":"2006","journal-title":"Diabetes Technol. Ther."},{"key":"10.1016\/j.jad.2020.06.040_bib0044","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1046\/j.1523-1747.2001.01285.x","article-title":"Autofluorescence of human skin is age-related after correction for skin pigmentation and redness","volume":"116","author":"Na","year":"2001","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jad.2020.06.040_bib0045","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1080\/15622975.2018.1433325","article-title":"Anxiety disorders and CRP in a population cohort study with 54,326 participants: the LifeLines study","volume":"19","author":"Naude","year":"2018","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2020.06.040_bib0046","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1017\/S1461145707008401","article-title":"Oxidative stress in psychiatric disorders: evidence base and therapeutic implications","volume":"11","author":"Ng","year":"2008","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2020.06.040_bib0047","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1093\/eurheartj\/ehl338","article-title":"Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies","volume":"27","author":"Nicholson","year":"2006","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.jad.2020.06.040_bib0048","first-page":"A1784","article-title":"[Depression and somatic comorbidity]","volume":"154","author":"Penninx","year":"2010","journal-title":"Ned. Tijdschr. Geneeskd."},{"key":"10.1016\/j.jad.2020.06.040_bib0049","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/3818196","article-title":"Advanced Glycation End Products (AGEs): biochemistry, Signaling, Analytical Methods, and Epigenetic Effects","volume":"2020","author":"Perrone","year":"2020","journal-title":"Oxid. Med. Cell Longev."},{"key":"10.1016\/j.jad.2020.06.040_bib0050","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.atherosclerosis.2005.06.001","article-title":"Anxiety in relation to inflammation and coagulation markers, among healthy adults: the ATTICA study","volume":"185","author":"Pitsavos","year":"2006","journal-title":"AtherosclerosisAtherosclerosis"},{"key":"10.1016\/j.jad.2020.06.040_bib0051","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.genhosppsych.2015.12.003","article-title":"Excess mortality due to depression and anxiety in the United States: results from a nationally representative survey","volume":"39","author":"Pratt","year":"2016","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.jad.2020.06.040_bib0052","unstructured":"R Core Team, 2019. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria."},{"key":"10.1016\/j.jad.2020.06.040_bib0053","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/hup.829","article-title":"Major depressive disorder is accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidative-antioxidative systems","volume":"22","author":"Sarandol","year":"2007","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.jad.2020.06.040_bib0054","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/ije\/dyu229","article-title":"Cohort Profile: lifeLines, a three-generation cohort study and biobank","volume":"44","author":"Scholtens","year":"2015","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.jad.2020.06.040_bib0055","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jpsychores.2014.10.007","article-title":"Depression, anxiety and 6-year risk of cardiovascular disease","volume":"78","author":"Seldenrijk","year":"2015","journal-title":"J. Psychosom. Res."},{"key":"10.1016\/j.jad.2020.06.040_bib0056","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jad.2018.05.079","article-title":"Depression and anxiety symptoms are associated with prooxidant-antioxidant balance: a population-based study","volume":"238","author":"Shafiee","year":"2018","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2020.06.040_bib0057","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/mp.2013.183","article-title":"Internalizing disorders and leukocyte telomere erosion: a prospective study of depression, generalized anxiety disorder and post-traumatic stress disorder","volume":"19","author":"Shalev","year":"2014","journal-title":"Mol. Psychiatry"},{"issue":"Suppl 20","key":"10.1016\/j.jad.2020.06.040_bib0058","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jad.2020.06.040_bib0059","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1037\/a0035302","article-title":"From stress to inflammation and major depressive disorder: a social signal transduction theory of depression","volume":"140","author":"Slavich","year":"2014","journal-title":"Psychol. Bull."},{"key":"10.1016\/j.jad.2020.06.040_bib0060","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s10654-007-9204-4","article-title":"Universal risk factors for multifactorial diseases: lifeLines: a three-generation population-based study","volume":"23","author":"Stolk","year":"2008","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.jad.2020.06.040_bib0061","series-title":"Flexible Imputation of Missing Data","author":"van Buuren","year":"2012"},{"key":"10.1016\/j.jad.2020.06.040_bib0062","first-page":"1","article-title":"mice: multivariate Imputation by Chained Equations in R","volume":"45","author":"van Buuren","year":"2011","journal-title":"J. Stat. Softw."},{"key":"10.1016\/j.jad.2020.06.040_bib0063","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/da.22527","article-title":"Advanced glycation end product (AGE) accumulation in the skin is associated with depression: the maastricht study","volume":"34","author":"van Dooren","year":"2017","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jad.2020.06.040_bib0064","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00125-018-4769-x","article-title":"Skin autofluorescence predicts incident type 2 diabetes, cardiovascular disease and mortality in the general population","volume":"62","author":"van Waateringe","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/j.jad.2020.06.040_bib0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179330","article-title":"The association between various smoking behaviors, cotinine biomarkers and skin autofluorescence, a marker for advanced glycation end product accumulation","volume":"12","author":"van Waateringe","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jad.2020.06.040_bib0066","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13098-017-0241-1","article-title":"Skin autofluorescence, a non-invasive biomarker for advanced glycation end products, is associated with the metabolic syndrome and its individual components","volume":"9","author":"van Waateringe","year":"2017","journal-title":"Diabetol. Metab. Syndr."},{"key":"10.1016\/j.jad.2020.06.040_bib0067","series-title":"Modern Applied Statistics With S","author":"Venables","year":"2002"},{"key":"10.1016\/j.jad.2020.06.040_bib0068","doi-asserted-by":"crossref","first-page":"39027","DOI":"10.1074\/jbc.M006700200","article-title":"Effect of collagen turnover on the accumulation of advanced glycation end products","volume":"275","author":"Verzijl","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"Suppl 1","key":"10.1016\/j.jad.2020.06.040_bib0069","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/10715762.2013.815348","article-title":"Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation","volume":"47","author":"Vistoli","year":"2013","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.jad.2020.06.040_bib0070","doi-asserted-by":"crossref","first-page":"e249","DOI":"10.1038\/tp.2013.27","article-title":"Anxiety disorders and inflammation in a large adult cohort","volume":"3","author":"Vogelzangs","year":"2013","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jad.2020.06.040_bib0071","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1038\/npp.2014.9","article-title":"Inflammatory and metabolic dysregulation and the 2-year course of depressive disorders in antidepressant users","volume":"39","author":"Vogelzangs","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2020.06.040_bib0072","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1038\/tp.2012.8","article-title":"Association of depressive disorders, depression characteristics and antidepressant medication with inflammation","volume":"2","author":"Vogelzangs","year":"2012","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jad.2020.06.040_bib0073","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology [WHO], 2019. Norwegian Institute of Public Health. Guidelines for ATC classification and DDD assignment 2019."},{"key":"10.1016\/j.jad.2020.06.040_bib0074","first-page":"II2","article-title":"Inflammation as a cardiovascular risk factor","volume":"109","author":"Willerson","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jad.2020.06.040_bib0075","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1001\/2013.jamapsychiatry.102","article-title":"Elevated C-reactive protein levels, psychological distress, and depression in 73, 131 individuals","volume":"70","author":"Wium-Andersen","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jad.2020.06.040_bib0076","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4161\/oxim.3.2.11148","article-title":"Advanced glycation end products, oxidative stress and diabetic nephropathy","volume":"3","author":"Yamagishi","year":"2010","journal-title":"Oxid. Med. Cell Longev."},{"key":"10.1016\/j.jad.2020.06.040_bib0077","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.bcp.2019.05.027","article-title":"Apigenin and its methylglyoxal-adduct inhibit advanced glycation end products-induced oxidative stress and inflammation in endothelial cells","volume":"166","author":"Zhou","year":"2019","journal-title":"Biochem. Pharmacol."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032720324290?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032720324290?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T01:42:54Z","timestamp":1759023774000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032720324290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":77,"alternative-id":["S0165032720324290"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2020.06.040","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between skin autofluorescence of advanced glycation end products and affective disorders in the lifelines cohort study","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2020.06.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}